FindMyKOL
Clinical trialNCT01322360CompletedPhase 4Interventional

Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects

SponsorRoxane LaboratoriesEnrollment50Pain
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the tolerability and safety of oral morphine sulfate in the treatment of postoperative pain in different pediatric age groups following multiple-dose administration. To determine multiple-dose pharmacokinetics (PK) of morphine sulfate in pediatric subjects. To compare plasma concentration of morphine sulfate in each age group of pediatric subjects with adult plasma morphine sulfate concentrations.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Maricopa Integrated Health System

    Phoenix, Arizona, United States

  • Arkansas Children'S Hospital

    Little Rock, Arkansas, United States

  • Stanford University Medical Center

    Stanford, California, United States

  • Yale New Haven Children'S Hospital

    New Haven, Connecticut, United States

  • Children'S National Medical Center

    Washington D.C., District of Columbia, United States

  • Children'S Hospital of Michigan

    Detroit, Michigan, United States

  • Children'S Hospital Medical Center of Akron D/b/a Akron Children'S Hospital

    Akron, Ohio, United States

  • Penn State Milton S. Hershey Medical Center

    Hershey, Pennsylvania, United States

  • Monroe Carell Jr. Children'S Hospital at Vanderbilt

    Nashville, Tennessee, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • University of Texas Health Science Center of Houston

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2011
Primary completion
30 Apr 2012
Completion
30 Apr 2012
Last update posted
5 Feb 2018
Registered enrollment
50
Registry id
NCT01322360

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.